Juvenile idiopathic arthritis. II. Treatment and prognosis

Quartier, P.; Prieur, A.-M.

La Revue du Praticien 57(12): 1289-1293

2007


ISSN/ISBN: 0035-2640
PMID: 17717939
Document Number: 606651
Immunosuppressants, including methotrexate and more recently anti-TNFalpha, have modified the prognosis of the most severe forms juvenile idiopathic arthritis. However, the therapeutic management is still challenging and adjuvant therapies, including physiotherapy, surgery, or even bisphosphonates and growth hormone, are still widely used to limit the negative impact of an extended general corticotherapy.

Document emailed within 1 workday
Secure & encrypted payments